Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections Raichur & Hyderabad, India – ...

Chemotherapy-induced nausea and vomiting (CINV) represents one of the most distressing and debilitating side effects experienced by cancer patients undergoing treatment, significantly impacting ...

The Delhi High Court in India has upheld the grant of a pharmaceutical patent to privately-held Swiss drugmaker Helsinn Healthcare for its nausea medication, an orally administered dosage form ...

Shilpa Medicare has announced its intention to pursue a US approval within the next two years and is actively seeking licensing partners for its ondansetron extended-release injection (OERIS), ...